|1||NCT02926911||Recruiting||Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS||
||1200||Female||40 Years to 99 Years (Adult, Senior)||NCT02926911||AFT-25||COMET||February 22, 2017||June 2021||July 2021||October 6, 2016||January 10, 2018||
|2||NCT01272037||Recruiting||Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer||
||10000||Female||18 Years and older (Adult, Senior)||NCT01272037||NCI-2011-02623
|January 15, 2011||February 1, 2022||January 7, 2011||February 23, 2018||
† Study has passed its completion date and status has not been verified in more than two years.